Royal Bank of Canada
IDXX icon

Royal Bank of Canada’s Idexx Laboratories IDXX Stock Holding History

Royal Bank of Canada’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8,000
Closed -$4.02M – 7300
2023
Q2 		$4.02M Buy
+8,000
New +$3.83M ﹤0.01% 2265

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Royal Bank of Canada's IDXX Position: Q2 2026 in Review

Royal Bank of Canada reduced its Idexx Laboratories (IDXX) stake by 30% in Q2 2026, selling an estimated $65.8M and leaving 274,340 shares worth $144M. The position accounts for 0.02% of the portfolio, ranked #553.

Royal Bank of Canada first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $269M in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Royal Bank of Canada held 274,340 shares of Idexx Laboratories worth $144M as of Q2 2026.
  • Royal Bank of Canada sold 117,364 Idexx Laboratories shares in Q2 2026, an estimated $65.8M.
  • Idexx Laboratories made up 0.02% of Royal Bank of Canada's portfolio in Q2 2026, its #553 holding.
  • Royal Bank of Canada first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • Royal Bank of Canada's Idexx Laboratories position peaked at $269M in Q4 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.